Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2026

Conditions
Hematologic MalignancyStem Cell Transplant Complications
Interventions
COMBINATION_PRODUCT

Beijing protocol

"For patients \<55 years and HCT-CI≤ 3:Ara-C(4g/m2/day,-9 days),Bu(9.6mg/kg,-8 days to -6 days),Cy(1,800mg/m2/day,-5 days to -4 days),semustine(250mg/m2,-3 days),ATG(7.5-10 mg/kg,-5 to -2 days)~For patients ≥ 55 years or HCI-CI\>3:Ara-C(2g/m2/day,-10 days to -9 days),Bu(9.6mg/kg,-8 days to -6 days),Flu(30mg/m2/day,-6 days to -2 days),Cy(1,000mg/m2/day,-5 days to -4 days),semustine(250mg/m2,-3 days),ATG(7.5-10 mg/kg,-5 to -2 days)."

Trial Locations (1)

100044

RECRUITING

Deparment of Hematology, Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER